Literature DB >> 8615379

Case report: ofloxacin-induced hypersensitivity vasculitis.

R Pipek1, S Vulfsons, E Wolfovitz, Y Har-Shai, A Taran, I J Peled.   

Abstract

Since its introduction in 1985, the new fluoroquinolone antibiotic ofloxacin has gained widespread use, and much information has accumulated about its possible adverse effects. Skin reactions have been uncommon, and there have been very few reports about hypersensitivity vasculitis directly related to ofloxacin. The authors report such a case, in which the patient needed plastic surgery because of severe vasculitis in both legs.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8615379     DOI: 10.1097/00000441-199602000-00005

Source DB:  PubMed          Journal:  Am J Med Sci        ISSN: 0002-9629            Impact factor:   2.378


  5 in total

1.  Orbital inflammatory pseudotumor due to hypersensitivity vasculitis and mononeuritis multiplex in a patient with atypical, cANCA-positive Wegener's granulomatosis.

Authors:  Jörg Kaufmann; Eberhard Schulze; Ulrich Voigt; Jürgen Strobel; Gert Hein; Günter Stein
Journal:  Rheumatol Int       Date:  2003-04-17       Impact factor: 2.631

2.  Cutaneous vasculitis associated with fluoroquinolones.

Authors:  G Maunz; T Conzett; W Zimmerli
Journal:  Infection       Date:  2009-08-07       Impact factor: 3.553

Review 3.  Ceftriaxone-induced leukocytoclastic vasculitis: a case report and literature review of antibiotic-induced leukocytoclastic vasculitis.

Authors:  Aseel A Almasoudi; Eman S Bablghaith; Samaher I Alaauldeen; Ayman M Falemban; Ahlam A Sherbeeni; Adeeb A Bulkhi
Journal:  J Int Med Res       Date:  2022-05       Impact factor: 1.573

4.  Ofloxacin induced leucopenia in complicated falciparum malaria: a case report.

Authors:  Swagata Tripathy; Amit Adhya
Journal:  Cases J       Date:  2009-06-09

5.  Cutaneous leukocytoclastic vasculitis associated with levofloxacin therapy.

Authors:  Dana M Blyth; Elizabeth Markelz; Jason F Okulicz
Journal:  Infect Dis Rep       Date:  2012-01-30
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.